+10.35%/+9.52%/+9.81%/+12.79%。分渠道看，公司优化渠道，线上渠道维持较快增长。2025H1，公司 线下渠道与线上渠道分别实现营收137.20亿元/8.42亿元，同比分别+9.07%/+38.97%。 2025Q2公司盈利水平同比提升。受益于大豆等原材料价格下降叠加产品结构优化，2025Q2公司毛利率 同比增加3.88个百分点至40.21%。费用方面，2025Q2公司销售费用率/管理费用率分别为6.95%/2.30%， 同比分别+0.35pct/+0.17pct。综合毛利率与费用率的情况，2025Q2公司净利率为24.80%，同比增加1.01 个百分点，盈利水平同比提升。 点评： 公司2025Q2业绩稳健。2025年上半年，公司实现营业收入152.30亿元，同比增长7.59%；实现归母净利 润39.14亿元，同比增长13.35%。分季度看，二季度消费弱复苏，公司作为行业龙头积极优化产品与渠 道结构，Q2业绩稳健增长。2025Q2公司实现营业收入69.15亿元，同比增长7.00%；实现归母净利润 17.12亿元，同比增长11.57%。 主业表现稳健，线上渠道维持较快增长。分品类看，公司 ...

Core Viewpoint - The company has approved the use of idle raised funds for cash management and temporary working capital supplementation, ensuring that it does not affect the normal operation of fundraising projects and complies with relevant regulations [10][12][40]. Company Basic Information - The company has not undergone any changes in controlling shareholders or actual controllers during the reporting period [4][5]. - The company plans not to distribute cash dividends or issue bonus shares during the reporting period [3]. Financial Data and Indicators - The company raised a total of RMB 149,206.80 million from the issuance of convertible bonds, with a net amount of RMB 148,066.32 million after deducting issuance costs [20][42]. - As of June 30, 2025, the company has used RMB 56,302.46 million of the raised funds, with remaining funds and interest income netting RMB 92,365.97 million [44]. Important Matters - The company plans to issue convertible bonds with a conversion period from February 29, 2024, to August 22, 2029, with an initial conversion price of RMB 34.67 per share, which will be adjusted to RMB 27.65 per share starting October 30, 2024 [3][6]. - The company has approved the use of up to RMB 4 billion of idle raised funds for cash management, with a focus on low-risk, high-liquidity products [10][30]. - The company has also approved the temporary supplementation of working capital using up to RMB 8 billion of idle raised funds, ensuring that it does not affect the normal operation of fundraising projects [39][40]. Board and Supervisory Opinions - The board and supervisory committee have unanimously approved the cash management and temporary working capital supplementation proposals, confirming compliance with relevant regulations [11][12][39].

上海妙道企业管理咨询有限公司 关于 国轩高科股份有限公司 第五期员工持股计划（草案） 之 独立财务顾问报告 独立财务顾问： 二〇二五年八月 上海妙道企业管理咨询有限公司 独立财务顾问报告 目 录 四、对本员工持股计划是否存在明显损害上市公司及全体股东利益情形的核查意见 26 上海妙道企业管理咨询有限公司 独立财务顾问报告 五、本独立财务顾问未委托和授权任何其它机构和个人提供未在本独立财务 上海妙道企业管理咨询有限公司 独立财务顾问报告 顾问报告中列载的信息和对本独立财务顾问报告做任何解释或者说明。 第一章 声明 上海妙道企业管理咨询有限公司接受委托，担任国轩高科股份有限公司（以 下简称"国轩高科""上市公司"或"公司"）第五期员工持股计划（以下简称 "本员工持股计划"）的独立财务顾问（以下简称"本独立财务顾问"），并制 作本独立财务顾问报告。本独立财务顾问报告是根据《中华人民共和国公司法》 《中华人民共和国证券法》《关于上市公司实施员工持股计划试点的指导意见》 及《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范运作》 等法律、法规和规范性文件的有关规定，在国轩高科提供有关资料的基础上，发 表独立 ...

腾景科技股份有限公司 2025 年员工持股计划（草案）摘要 证券简称：腾景科技 证券代码：688195 腾景科技股份有限公司 二〇二五年八月 腾景科技股份有限公司 2025 年员工持股计划（草案）摘要 声明 本公司及全体董事、监事保证本员工持股计划及其摘要不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担 法律责任。 腾景科技股份有限公司 2025 年员工持股计划（草案）摘要 风险提示 一、腾景科技股份有限公司（以下简称"腾景科技""公司"或"本公司"） 股东大会批准后方可实施，本员工持股计划草案能否获得公司股东大会批准，存 在不确定性。 二、有关公司 2025 年员工持股计划（以下简称"本员工持股计划"）的 具体的资金来源、出资金额、预计规模和具体实施方案等属初步结果，能否 完成实施，存在不确定性。 三、若员工认购资金较低，本员工持股计划存在无法成立的风险；若员 工认购份额不足，本员工持股计划存在低于预计规模的风险。 四、股票价格受公司经营业绩、宏观经济周期、国际/国内政治经济形势及 投资者心理等多种复杂因素影响。因此，股票交易是有一定风险的投资活动，投 资者对此应有充 ...

腾景科技股份有限公司 2025 年员工持股计划（草案） 证券简称：腾景科技 证券代码：688195 腾景科技股份有限公司 二〇二五年八月 腾景科技股份有限公司 2025 年员工持股计划（草案） 声明 本公司及全体董事、监事保证本员工持股计划及其摘要不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担 法律责任。 腾景科技股份有限公司 2025 年员工持股计划（草案） 风险提示 一、腾景科技股份有限公司（以下简称"腾景科技""公司"或"本公司"） 股东大会批准后方可实施，本员工持股计划草案能否获得公司股东大会批准，存 在不确定性。 二、有关公司 2025 年员工持股计划（以下简称"本员工持股计划"）的 具体的资金来源、出资金额、预计规模和具体实施方案等属初步结果，能否 完成实施，存在不确定性。 三、若员工认购资金较低，本员工持股计划存在无法成立的风险；若员 工认购份额不足，本员工持股计划存在低于预计规模的风险。 四、股票价格受公司经营业绩、宏观经济周期、国际/国内政治经济形势及 投资者心理等多种复杂因素影响。因此，股票交易是有一定风险的投资活动，投 资者对此应有充分准备。 五 ...

腾景科技股份有限公司 二〇二五年八月 第一章 总则 第一条 为规范腾景科技股份有限公司（以下简称"腾景科技"或"公司"） 施，根据《中华人民共和国公司法》 （以下简称" （以下简称"《指导意见》"）、 《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作》 （以下简称"《自律监管指引》"）等相关法律、 行政法规、部门规章、规范性文件和《公司章程》之规定，特制定本管理办法。 第二章 员工持股计划的制定 《公司法》"）、 《中华人民共和国 证券法》 （以下简称"《证券法》" ）、《中国证监会关于上市公司实施员工持股计划 试点的指导意见》 第二条 员工持股计划所遵循的基本原则 （一）依法合规原则 公司实施本员工持股计划，严格按照法律、行政法规的规定履行程序，真实、 准确、完整、及时地实施信息披露。任何人不得利用本员工持股计划进行内幕交 易、操纵证券市场等证券欺诈行为。 （二）自愿参与原则 公司实施本员工持股计划遵循公司自主决定，员工自愿参加的原则，公司不 以摊派、强行分配等方式强制员工参加本员工持股计划。 （三）风险自担原则 本员工持股计划参与人盈亏自负，风险自担，与其他投资者权益平等。 第三条 员工 ...

Core Viewpoint - The legal opinion letter confirms that Ningbo Deye Technology Co., Ltd. has the qualifications to implement the 2025 Employee Stock Ownership Plan (ESOP) and that the plan complies with relevant laws and regulations [7][9][20]. Group 1: Company Qualifications - Ningbo Deye Technology Co., Ltd. was established as a joint-stock company in 2017 and is listed on the Shanghai Stock Exchange with the stock code 605117 [7][8]. - The company has a registered capital of 638.11 million yuan and operates in various sectors including the development and manufacturing of heat exchangers and air purification equipment [8]. Group 2: Legality and Compliance of the ESOP - The ESOP has been approved by the company's board and supervisory committee, ensuring compliance with the relevant legal frameworks [9][10]. - The plan includes provisions to prevent insider trading and ensures voluntary participation from employees, aligning with regulatory guidelines [10][11]. Group 3: Legal Procedures for Implementation - The company has completed necessary legal procedures for the ESOP, including meetings and approvals from relevant committees [18]. - The ESOP requires further approval from the shareholders' meeting to be fully implemented [18][19]. Group 4: Information Disclosure - The company has disclosed relevant information regarding the ESOP in accordance with the requirements of the China Securities Regulatory Commission and the stock exchange [19][20]. - Continuous information disclosure obligations will be maintained as the ESOP progresses [19].

Core Viewpoint - The board of directors of Guangxi Liuyuan Pharmaceutical Group Co., Ltd. held its 28th meeting, approving several key proposals including the half-year report and various governance changes aimed at enhancing operational efficiency and corporate governance [1][2][3]. Meeting Details - The board meeting was held on August 28, 2025, with all 7 directors present, ensuring compliance with legal and procedural requirements [1]. Financial Reports - The board approved the 2025 half-year report and its summary, with unanimous support from all directors [2]. - A special report on the use of raised funds was also approved, reflecting accurate management of funds during the reporting period [2]. Governance Changes - The board approved a proposal to change the registered capital and abolish the supervisory board, transferring some supervisory functions to the audit committee [3][4]. - A comprehensive revision of the company's articles of association was proposed to align with governance and regulatory requirements [3][4]. Risk Management - The board proposed purchasing liability insurance for directors and senior management to mitigate operational risks, with the proposal to be submitted to the shareholders' meeting due to conflicts of interest [7]. Incentive Plans - The board approved a draft for the 2025 stock option incentive plan aimed at attracting and retaining talent, which will also be submitted for shareholder approval [10][11]. - A management method for the stock option incentive plan was also approved, ensuring alignment with corporate goals [11][12]. Employee Stock Ownership Plan - The board approved a draft for the 2025 employee stock ownership plan to enhance employee engagement and align interests with shareholders, pending shareholder approval [15][16]. - A management method for the employee stock ownership plan was also established, ensuring compliance with relevant regulations [16][17]. Upcoming Meetings - The board scheduled the second extraordinary shareholders' meeting for September 15, 2025, to review the approved proposals [18].

Core Viewpoint - The company has conducted a necessary review of its 2025 Employee Stock Ownership Plan (ESOP) and has confirmed that the plan complies with relevant laws and regulations, aiming to enhance corporate governance and employee engagement [1][2]. Group 1: Compliance and Legal Framework - The review by the company's Compensation and Assessment Committee indicates that the ESOP adheres to the Company Law, Securities Law, and other regulatory guidelines [1]. - The plan's content is in line with the prohibitions outlined in the self-regulatory guidelines, ensuring that there are no circumstances that would prevent the implementation of the ESOP [1][2]. Group 2: Employee Participation and Benefits - The ESOP does not involve any forced participation or financial assistance from the company to the plan participants, ensuring voluntary engagement [2]. - The plan is designed to improve corporate governance, attract and retain talented management and key personnel, and enhance employee cohesion and company competitiveness [2].

Group 1 - The core point of the announcement is the approval of the employee stock ownership plan (ESOP) by the board of directors, aimed at enhancing the company's governance and competitiveness while motivating employees [1][2][3] - The board meeting was held on August 28, 2025, with all five directors present, and the proposal for the ESOP received four votes in favor, with one director abstaining due to potential conflict of interest [1][2] - The ESOP is set to be submitted for approval at the company's first extraordinary general meeting of shareholders in 2025 [2][3] Group 2 - The company plans to implement the ESOP in accordance with relevant laws and regulations, including the Company Law and Securities Law, and has drafted the "2025 Employee Stock Ownership Plan (Draft)" [2][3] - The board has proposed to authorize itself to handle all matters related to the ESOP, including establishment, changes, and termination of the plan, as well as decisions regarding stock lock-up and release [3][4] - The board also approved the appointment of Mr. Yang Shuai as the company secretary, with a term lasting until the end of the current board's tenure [5][6] Group 3 - The company has scheduled its first extraordinary general meeting of shareholders for September 15, 2025, to discuss the ESOP and other matters [5][6] - The board's resolutions from the meeting, including the ESOP and the appointment of the company secretary, will be made available for public review [5][6]